This page lists feature articles on COVID-19 relevant to people working at St Vincent's Health Australia.
All articles listed are open access unless stated otherwise.
Therapy
Inhaled nebulised unfractionated heparin for the treatment of hospitalised patients with COVID-19: a multicentre case series of 98 patients. SVHA
British Journal of Clinical Pharmacology:2022: January 4 Full text
Clinical Practice
Should COVID-19 vaccinations be mandatory? AUS
Internal Medicine Journal:2022: January 20 Full text
Universal SARS-CoV-2 testing of emergency department admissions increases emergency department length of stay.
Annals of Emergency Medicine:2022:79(2):182-86 Full text
The impact of acute surgical unit rostering on National Emergency Access Targets during the COVID-19 Pandemic: a single hospital experience. AUS
ANZ Journal of Surgery:2022: January 18 Full text
Optimizing surgical training in the time of COVID-19—Victorian regional teaching hospital experience. AUS
ANZ Journal of Surgery:2022: January 12 Full text
Influence of COVID-19 on the next generation of nurses in the United States.
Journal of Clinical Nursing:2022: January 18 Full text
Healthcare use in 700 000 children and adolescents for six months after covid-19: before and after register based cohort study.
BMJ: 2022:376:e066809 Full text
Pathophysiology and Long COVID
Nervous system consequences of COVID-19.
Science:2022: January 20 Full text
Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease.
Brain:2021:144(12):3576-88 Full text
HEMATOLOGICAL CHANGES IN SARS-COV-2 POSITIVE PATIENTS.
Hematology, Transfusion and Cell Therapy:2022: January 24 Full text
Dysphagia characteristics of patients post SARS-CoV-2 during inpatient rehabilitation.
Archives of Physical Medicine and Rehabilitation:2022:103(2):336-41 Full text
Multiple early factors anticipate post-acute COVID-19 sequelae.
Cell:2022: January 24 Full text
Epidemiology
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study.
Lancet:2022: January 19 Full text
Vaccines
Immunogenicity and reactogenicity of vaccine boosters after Ad26.COV2.S priming.
New England Journal of Medicine:2022: January 19 Full text
Neutralization of Omicron SARS-CoV-2 by 2 or 3 doses of BNT162b2 vaccine.
bioRxiv:2022: January 22 Full text
Association between 3 doses of mRNA COVID-19 vaccine and symptomatic infection caused by the SARS-CoV-2 Omicron and Delta variants.
JAMA:2022: January 21 Full text
Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipients.
Cell: 2022: January 19 Full text
Homologous and heterologous Covid-19 booster vaccinations.
New England Journal of Medicine:2022: January 26 Full text
Vaccine Adverse Effects
Pfizer/BioNtech BNT162b2: adverse events and insights from an Australian mass vaccination clinic for COVID-19. AUS
Internal Medicine Journal:2022: January 20 Full text
